Abstract:Ethnopharmacological relevance Acteoside (ACT) is the main ingredient derived from the leaves of Rehmannia glutinosa (Dihuangye). Dihuangye has the function of clearing heat, replenishing qi and activating blood, nourishing yin and tonifying kidney in traditional Chinese medicine. Recent studies have demonstrated that Dihuangye can be used to treat nephritis and ACT is a promising antinephritic agent. Aim of the study To clarify the metabolites of ACT in biological samples and investigate the renoprotective effect and mechanism of ACT in rats with chronic glomerulonephritis (CGN). Materials and methods In this study, the biotransformation of ACT in rat biological samples was clarified by quadrupole time-of-flight tandem mass spectrometry. The metabolites were validated by urine samples in nephropathy model rats. The effect of ACT and its metabolites was evaluated by glomerular podocyte injury due to high glucose. Based on an analysis of the ingredients in vivo , the potential therapeutic targets in the treatment of CGN were investigated by using network pharmacological analysis and molecular docking. Then, the renoprotective effect and mechanism of ACT were determined in rats in a passive Heymann nephritis (PHN) model. Results A total of 49 metabolites of ACT were detected and identified. Meanwhile, 21 metabolites were detected in nephropathy model rats. ACT was absorbed rapidly and transferred from the kidney, and the metabolites were eliminated via urine. The whole process lasted approximately 8 h. ACT had a significant protective effect on glomerular podocytes damaged by high glucose and 3,4-dihydroxyphenylacetic acid might be the main metabolite of ACT underlying its functions in vivo . The network pharmacology and molecular docking results showed 84 ACT-CGN targets, among which MAPK1, HRAS, AKT1, EGFR, and others were a highly correlated. In the PHN rat model, ACT significantly reduced the 24-h urine protein and serum creatinine concentrations, suppressed the leukocyte CD18 expression levels, decreased the serum tumor necrosis factor α (TNF-α) levels and tended to reduce serum interleukin 6 (IL-6) levels. ACT significantly reduced the platelet aggregation rate and inhibited the proliferative activity of splenic lymphocytes in response to the mitogen concanavalin A. Meanwhile, ACT inhibited transforming growth factor-β and fibronectin expression in renal tissues and dose-dependently inhibited TNF-α and IL-6 production in RAW264.7 mouse macrophages at doses ranging from 1.8 to 1330 μg/mL. Conclusions ACT had therapeutic effects on PHN rats, and its mechanism might be related to the inhibition of intercellular or intercellular-matrix adhesion, suppression of inflammatory response, regulation of immune function, improvement of tissue hemodynamics and hemorheology, and relief of fibrotic lesions.

Mechanism of adrenocorticotropic hormone in the treatment of nephrotic syndrome

Efficacy of adrenocorticotropic hormone in treating primary nephrotic syndrome in children with dual resistance to glucocorticoids and calcineurin inhibitors

[Efficacy of adrenocorticotropic hormone in children with frequently relapsing or steroid-dependent nephrotic syndrome]

Real-word adrenocorticotropic hormone treatment for childhood-onset nephrotic syndrome

Natural Adrenocorticotropic Hormone (ACTH) Relieves Acute Inflammation in Gout Patients by Changing the Function of Macrophages.

Effect of Astragalus Membranaceus on Hypertenison and Mechanisms Investigation in Spontaneously Hypertensive Rats

Studies on the metabolism and mechanism of acteoside in treating chronic glomerulonephritis

Efficacy and Safety of Glucocorticoids Therapy for IgA Nephropathy: a Meta-Analysis of Randomized Controlled Trials.

ACTH4-10 protects the ADR-injured podocytes by stimulating B lymphocytes to secrete interleukin-10

Enhanced Steroid Therapy In Adult Minimal Change Nephrotic Syndrome: A Systematic Review And Meta-Analysis

Α‐actinin‐4 is Involved in the Process by Which Dexamethasone Protects Actin Cytoskeleton Stabilization from Adriamycin‐induced Podocyte Injury

ACTH treatment promotes murine cardiac allograft acceptance

Regulation Of The Egfr Pathway By Hsp90 Is Involved In The Pathogenesis Of Cushing'S Disease

Regulation of the EGFR Pathway by HSP90 Is Involved in the Pathogenesis of Cushing’s Disease

The Mechanism by Which Cyclosporin A Inhibits Cardiac Hypertrophy in Renal Hypertension Rats

IgA Nephropathy with Nephrotic Syndrome: Clinicopathologic Features and Prednisone Therapy

Selective Inhibition of Histone Deacetylase Class IIa With MC1568 Ameliorates Podocyte Injury

Protective effect of adrenomedullin on human renal tubulointerstitial lesion

Understanding negative feedback: Changes in high-molecular-weight adrenocorticotropic hormone in adrenocorticotropic hormone-independent Cushing's syndrome

ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation

Diversities of podocyte molecular changes induced by different antiproteinuria drugs.